Antitumor effects and biological mechanism of action of the aqueous extract of the camptotheca acuminata fruit in human endometrial carcinoma cells

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Lin, Chi Shian ^a   Chen, Pin Chien ^b   Wang, Chien Kai ^c,d   Wang, Chia Woei ^c,d   Chang, Yu Jia ^a,d,e   Tai, Cheng Jeng ^c,d   Tai, Chen Jei ^c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Chiali Hospital   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CASPASE 3; CASPASE 7; CISPLATIN; CYCLIN A; CYCLIN A2; CYCLIN B1; CYCLIN E; PROCASPASE 7; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CAMPTOTHECA ACUMINATA; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL VIABILITY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MEDICINAL PLANT;

EID: 84902213845     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/564810     Document Type: Article

References (27)

1. Amant F., Moerman P., Neven P., Timmerman D., van Limbergen E., Vergote I., Endometrial cancer. The Lancet 2005 366 9484 491 505 2-s2.0-23444461364 10.1016/S0140-6736(05)67063-8
2. Bray F., Loos A. H., Oostindier M., Weiderpass E., Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe. International Journal of Cancer 2005 117 1 123 131 2-s2.0-18544373204 10.1002/ijc.21099
3. Aalders J. G., Abeler V., Kolstad P., Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecologic Oncology 1984 17 1 85 103 2-s2.0-0021349366
4. Podratz K. C., O'Brien P. C., Malkasian G. D. Jr., Decker D. G., Jefferies J. A., Edmonson J. H., Effects of progestational agents in treatment of endometrial carcinoma. Obstetrics & Gynecology 1985 66 1 106 110
5. Lorence A., Nessler C. L., Camptothecin, over four decades of surprising findings. Phytochemistry 2004 65 20 2735 2749 2-s2.0-4944264246 10.1016/j.phytochem.2004.09.001
6. Kepler J. A., Wani M. C., McNaull J. N., Wall M. E., Levine S. G., Plant antitumor agents. IV. An approach toward the synthesis of camptothecin. The Journal of Organic Chemistry 1969 34 12 3853 3858 2-s2.0-0014634987
7. Hsiang Y.-H., Liu L. F., Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Research 1988 48 7 1722 1726 2-s2.0-0023924786
8. Hsiang Y.-H., Liu L. F., Wall M. E., Wani M. C., Nicholas A. W., Manikumar G., Kirschenbaum S., Silber R., Potmesil M., DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Research 1989 49 16 4385 4389 2-s2.0-0024356003
9. Svejstrup J. Q., Christiansen K., Gromova I. I., Andersen A. H., Westergaard O., New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. Journal of Molecular Biology 1991 222 3 669 678 2-s2.0-0026351183
10. Rodriguez-Hernandez A., Brea-Calvo G., Fernandez-Ayala D. J., Cordero M., Navas P., Sanchez-Alcazar J. A., Nuclear caspase-3 and capase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis. Apoptosis 2006 11 1 131 139 2-s2.0-31444457080 10.1007/s10495-005- 3276-y
11. Owonikoko T. K., Aisner J., Wang X. V., Dahlberg S. E., Rubin E. H., Ramalingam S. S., Gounder M., Rausch P. G., Axelrod R. S., Schiller J. H., E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer. Cancer Chemotherapy and Pharmacology 2014 73 1 171 180 10.1007/s00280-013-2338-z
12. Kim H. S., Kim J. H., Kim B., Choi H. C., Kwon J. H., Choi D. R., Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology 2013 71 6 1591 1597
13. Roy A., Cunningham D., Hawkins R., Sorbye H., Adenis A., Barcelo J. R., Lopez-Vivanco G., Adler G., Canon J. L., Lofts F., Castanon C., Fonseca E., Rixe O., Aparicio J., Cassinello J., Nicolson M., Mousseau M., Schalhorn A., D'Hondt L., Kerger J., Hossfeld D. K., Giron C. G., Rodriguez R., Schoffski P., Misset J. L., Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study. British Journal of Cancer 2012 107 3 435 441 10.1038/bjc.2012.286
14. Briasoulis E., Golfinopoulos V., Karina M., Papakostas P., Pavlidis N., Fountzilas G., Phase i trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study. Anti-Cancer Drugs 2010 21 8 785 789 2-s2.0-77955229329 10.1097/CAD.0b013e32833d5ec0
15. Chou T.-C., Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews 2006 58 3 621 681 2-s2.0-33748794547 10.1124/pr.58.3.10
16. Tai C. J., Wang C. K., Chang Y. J., Lin C. S., Tai C. J., Aqueous extract of Solanum nigrum leaf activates autophagic cell death and enhances docetaxel-induced cytotoxicity in human endometrial carcinoma cells. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 859185 10.1155/2012/859185
17. Tai C. J., Wang C. K., Tai C. J., Lin Y. F., Lin C. S., Jian J. Y., Chang Y. J., Chang C. C., Aqueous extract of Solanum nigrum leaves induces autophagy and enhances cytotoxicity of cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human colorectal carcinoma cells. Evidence-Based Complementary and Alternative Medicine 2013 2013 12 514719 10.1155/2013/514719
18. Tai C. J., Wang W. C., Wang C. K., Wu C. H., Yang M. D., Chang Y. J., Jian J. Y., Tai C. J., Fermented wheat germ extract induced cell death and enhanced cytotoxicity of cisplatin and 5-fluorouracil on human hepatocellular carcinoma cells. Evidence-Based Complementary and Alternative Medicine 2013 2013 9 121725 10.1155/2013/121725
19. Zhou Y., Gwadry F. G., Reinhold W. C., Miller L. D., Smith L. H., Scherf U., Liu E. T., Kohn K. W., Pommier Y., Weinstein J. N., Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Research 2002 62 6 1688 1695 2-s2.0-0037086088
20. Zhang R., Li Y., Cai Q., Liu T., Sun H., Chambless B., Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I. Cancer Chemotherapy and Pharmacology 1998 41 4 257 267 2-s2.0-0031984916 10.1007/s002800050738
21. 2 cells by 10- hydroxycamptothecin. Anti-Cancer Drugs 1999 10 6 569 576 2-s2.0-0032864365
22. Zhang J., Yu Y., Liu D., Liu Z., Extraction and composition of three naturally occurring anti-cancer alkaloids in Camptotheca acuminata seed and leaf extracts. Phytomedicine 2007 14 1 50 56 2-s2.0-33845610189 10.1016/j.phymed. 2006.11.004
23. Horwitz S. B., Horwitz M. S., Effects of camptothecin on the breakage and repair of DNA during the cell cyle. Cancer Research 1973 33 11 2834 2836 2-s2.0-0015692519
24. del Bino G., Skierski J. S., Darzynkiewicz Z., Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. Cancer Research 1990 50 18 5746 5750 2-s2.0-0025043807
25. 2 arrest: altered regulation of p34cdc2 /cyclin B. Cancer Research 1992 52 7 1823 1829 2-s2.0-0026625512
26. Borgne A., Versteege I., Mahe M., Studeny A., Léonce S., Naime I., Rodriguez M., Hickman J. A., Meijer L., Golsteyn R. M., Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. Oncogene 2006 25 56 7361 7372 2-s2.0-33845210398 10.1038/sj.onc.1209718
27. Kaufmann S. H., Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochimica et Biophysica Acta 1998 1400 1-3 195 211 2-s2.0-0032189262 10.1016/S0167-4781(98)00136-5